Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Mice without Vitamin D receptors have hair growth problems because of issues in the hedgehog signaling pathway.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Semaglutide may cause hair loss, but more research is needed to confirm this.

Medications for PCOS don't seem to raise heart disease risk.

Women with PCOS have a higher risk of heart disease.

Weight loss improves PCOS symptoms and overall health.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Methylene blue, combined with ceramides, may reduce skin and hair side effects from GLP-1 therapy.

PCOS and BED are linked, needing new treatment approaches focusing on mental health and eating habits.

Treating hirsutism and acne in women with PCOS needs a personalized approach using oral contraceptives, antiandrogens, and sometimes metformin.

PCOS is best managed with personalized lifestyle changes, medications, and sometimes surgery.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

PCOS treatment should be personalized based on individual symptoms and health goals.

Methylene blue helps hair growth by protecting hair stem cells from stress.

A comprehensive, personalized approach is needed for treating female pattern hair loss and obesity, involving multiple medical disciplines and lifestyle changes.

Semaglutide may help some skin disorders but can also cause skin issues.

Hair loss from weight-loss treatments is usually temporary and reversible.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Weight-loss drugs are not linked to suicidal thoughts.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

The new hair product quickly reduces hair shedding in women.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

A new topical solution safely reduces hair shedding by 38% on average by tightening a muscle in the scalp.